WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Endocyte, Inc., a biopharmaceutical company developing targeted small molecule drug conjugates, announced that it has entered into a loan and security agreement with MidCap Financial and Silicon Valley Bank, providing access to up to $15 million of capital to the company.
